Past Events

Interventions for managing ADHD include medications, such as stimulants (methylphenidate and amphetamines) and non-stimulants (eg, atomoxetine, bupropion, clonidine, guanfacine, and viloxazine), as well as non-pharmacological approaches such as behavioural therapies, dietary interventions, and neurofeedback. Current guidelines generally recommend medication—typically stimulants as first-line treatment and non-stimulants as second-line—combined with behavioural or cognitive behavioural therapies. Although many meta-analyses of randomised controlled trials have assessed ADHD treatments, their usefulness for clinicians is limited. They often focus on narrow outcomes, show conflicting results for the same interventions, and frequently do not assess evidence quality. Additionally, findings are mainly published in academic journals, limiting accessibility for people with ADHD, who have called for clearer, evidence-based online resources.

In this seminar, we will discuss the rationale and utility of neuropsychological evaluations for children and teens, and how it could help you understand and advocate for your child.

Trauma-Focused Cognitive Behavioral Therapy (TF-CBT) has the greatest amount of empirical evidence of any trauma treatment for children and families. This presentation will provide an overview of the TF-CBT model, a summary of the existing TF-CBT research, and a concrete description of a couple of recent TF-CBT outcome studies. Also, several TF-CBT modifications for different groups and implementation settings will be described.

In this seminar, will will review the symptoms and presentation of tics, and an evidence-based approach for treating tics, Habit Reversal Training.

Concerns about mental well-being are among the top discussion items in modern society. This is a welcome development when compared with a history of neglect and stigma, but it brings new challenges for psychiatry. More patients are accessing care than ever before and there is ever-greater demand for services. Yet existing treatments are only partially effective and come with significant side effect burden in most cases. This situation has turned a spotlight on psychiatry and demands a realistic assessment of current trends and challenges. Psychiatry can and should reform itself, but this should happen with patient well-being in focus and not in response to at-times hostile political attention and interference.